» Articles » PMID: 35706910

Risk Factors for COVID-19 Hospitalization in School-Age Children

Overview
Publisher Sage Publications
Specialty Public Health
Date 2022 Jun 16
PMID 35706910
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: With the recent emergence of the Omicron variant, there has been a rapid and alarming increase in the number of COVID-19 cases among pediatric populations. Yet few US pediatric cohort studies have characterized the clinical features of children with severe COVID-19. The objective of this study was to identify those chronic comorbidities that increase the risk of hospitalization for pediatric populations with severe COVID-19.

Methods: A retrospective cohort study that utilized the Texas Inpatient Public Use Data file was conducted. The study included 1187 patients (ages 5 to 19) from 164 acute-care Texas hospitals with the primary or secondary ICD-10CM diagnosis code U07.1 (COVID-19, virus identified). The baseline comparison group included 38 838 pediatric patients who were hospitalized in 2020. Multivariable binary logistic regression, controlling for patient characteristics, sociodemographic factors, and health insurance, was used to estimate the adjusted risk of hospitalization for COVID-19.

Results: Obesity and type 1 diabetes increased the risk of hospitalization with COVID-19 among both children (5-12 years) and adolescents (13-19 years). Adolescents with morbid obesity were 10 times more likely to have severe COVID-19 (p < 0.001). Regardless of age, single-parent households (%) for the patient's zip code was associated with an increased risk of hospitalization with COVID-19 (AOR = 1.02, CI: 1.01-1.03, p < 0.01). Other risk factors included chronic kidney disease (p < 0.05), male gender (p < 0.001), Medicaid (p < 0.001), and charity care (p < 0.001).

Conclusion: Pediatric providers and public health officials should consider the need to tailor clinical management and mitigation efforts for pediatric populations with identifiable risk factors for severe COVID-19. These findings can be used to improve risk communication with families of children with underlying medical conditions and to prioritize prevention measures, including vaccinations.

Citing Articles

Trends in the prevalence of obesity and estimation of the direct health costs attributable to child and adolescent obesity in Brazil from 2013 to 2022.

Nilson E, da Costa M, de Oliveira A, Honorio O, Barbosa R PLoS One. 2025; 20(1):e0308751.

PMID: 39820857 PMC: 11737795. DOI: 10.1371/journal.pone.0308751.


Clinical Features and Outcomes of Pediatric and Adult Patients Hospitalized for Coronavirus Disease 2019: A Comparison Across Age Strata.

Li G, Gopchandani K, Brazer N, Tippett A, Choi C, Hsiao H Open Forum Infect Dis. 2024; 11(8):ofae443.

PMID: 39183814 PMC: 11342389. DOI: 10.1093/ofid/ofae443.


Clinical characteristics of COVID-19 in children: a large multicenter study from Iran.

Hajialibeig A, Navaeifar M, Bordbari A, Hosseinzadeh F, Rostami-Maskopaee F, Rezai M Front Pediatr. 2024; 12:1398106.

PMID: 39108695 PMC: 11300238. DOI: 10.3389/fped.2024.1398106.


Proton Pump Inhibitors and Risk of COVID-19 Infection in Children.

Hirsch S, Liu E, Rosen R J Pediatr. 2024; 274:114179.

PMID: 38944187 PMC: 11536706. DOI: 10.1016/j.jpeds.2024.114179.


Clinical characteristics of pediatric patients with confirmed SARS-CoV-2 infection who followed rigorous measures during two years of the COVID-19 pandemic in a hospital in Mexico.

Ramirez-Cazares A, Hernandez-Ruiz Y, Martinez-Longoria C, Tamez-Gomez C, Medina-Macias O, Trevino-Montalvo R Front Pediatr. 2023; 11:1150738.

PMID: 37441570 PMC: 10333513. DOI: 10.3389/fped.2023.1150738.


References
1.
Kadri S, Gundrum J, Warner S, Cao Z, Babiker A, Klompas M . Uptake and Accuracy of the Diagnosis Code for COVID-19 Among US Hospitalizations. JAMA. 2020; 324(24):2553-2554. PMC: 7756233. DOI: 10.1001/jama.2020.20323. View

2.
Broadhurst R, Peterson R, Wisnivesky J, Federman A, Zimmer S, Sharma S . Asthma in COVID-19 Hospitalizations: An Overestimated Risk Factor?. Ann Am Thorac Soc. 2020; 17(12):1645-1648. PMC: 7706599. DOI: 10.1513/AnnalsATS.202006-613RL. View

3.
Singh A, Khunti K . Assessment of risk, severity, mortality, glycemic control and antidiabetic agents in patients with diabetes and COVID-19: A narrative review. Diabetes Res Clin Pract. 2020; 165:108266. PMC: 7286824. DOI: 10.1016/j.diabres.2020.108266. View

4.
Edwards K . Sparing of Severe Covid-19 in Vaccinated Adolescents. N Engl J Med. 2022; 386(8):789-790. PMC: 8781315. DOI: 10.1056/NEJMe2118471. View

5.
Tsankov B, Allaire J, Irvine M, Lopez A, Sauve L, Vallance B . Severe COVID-19 Infection and Pediatric Comorbidities: A Systematic Review and Meta-Analysis. Int J Infect Dis. 2020; 103:246-256. PMC: 7679116. DOI: 10.1016/j.ijid.2020.11.163. View